Login / Signup

Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From Four Large-Scale Placebo-Controlled Outcome Trials.

Brendon L NeuenBrian Lee ClaggettVlado PerkovicMeg J JardineHiddo J Lambers HeerspinkKenneth W MahaffeyJohn Joseph Valentine McMurrayScott D SolomonMuthiah Vaduganathan
Published in: Circulation (2024)
Keyphrases
  • placebo controlled
  • double blind
  • study protocol
  • phase iii
  • phase ii
  • phase ii study
  • clinical trial
  • randomized controlled trial
  • open label